Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Laurus Labs Limited
LAURUSLABSLaurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides oral solid formulations for ARVs, anti-diabetic, cardiovascular, and PPIs. In addition, the company offers contract development and manufacturing organizational services; and biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. Further, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India. Address: Serene Chambers, Hyderabad, India, 500034
Analytics
Precio Objetivo de WallStreet
47 253.13 INRRelación P/E
203.8163Rentabilidad por dividendo
0.17 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave LAURUSLABS
Análisis de dividendos LAURUSLABS
Aumento del dividendo durante 5 años
433 %Crecimiento continuo
–Ratio de pago medio en 5 años
37 %Tendencia del payout LAURUSLABS
Valoración de la acción LAURUSLABS
Finanzas LAURUSLABS
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |